PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-35.79%
Cash & equivalents declining -35.79% while GNPX's grows 1052.54%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
No Data
No Data available this quarter, please select a different quarter.
-35.79%
Below half of GNPX's 1052.54%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-31.27%
Higher Other Current Assets Growth compared to GNPX's zero value, indicating worse performance.
-32.53%
Below half of GNPX's 707.35%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-2.15%
Below half GNPX's 13.57%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.04%
Higher Other Non-Current Assets Growth compared to GNPX's zero value, indicating worse performance.
-1.56%
Below half of GNPX's 9.11%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-28.33%
Below half of GNPX's 597.19%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-12.11%
Less than half of GNPX's 46.33%. David Dodd sees a more disciplined AP approach or lower volume.
-29.66%
Higher Short-Term Debt Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
6.29%
Higher Deferred Revenue (Current) Growth compared to GNPX's zero value, indicating better performance.
100.00%
Less than half of GNPX's -20.95%. David Dodd sees fewer expansions in other current obligations.
-11.86%
Less than half of GNPX's 36.53%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Higher Other Non-Current Liabilities Growth compared to GNPX's zero value, indicating worse performance.
-7.08%
Higher Total Non-Current Liabilities Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-11.32%
Less than half of GNPX's 36.53%. David Dodd sees far fewer liability expansions relative to competitor.
6.25%
Less than half of GNPX's 70.53%. David Dodd sees fewer share issuances vs. competitor.
-2.72%
Below half GNPX's -13.75%. Michael Burry suspects major net losses or high dividends vs. competitor.
100.00%
Higher AOCI Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-46.50%
Below half GNPX's 691.88%. Michael Burry sees potential underperformance in building shareholder capital.
-28.33%
Below half GNPX's 597.19%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-8.76%
Less than half of GNPX's -100.00%. David Dodd sees less overall debt expansion vs. competitor.
40.72%
Less than half of GNPX's -1097.04%. David Dodd sees better deleveraging or stronger cash buildup than competitor.